3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
32
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
4
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Infertility
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasms by Site
1
Hypogonadism
1
Hot Flashes
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Anovulation
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Cisplatin
6
Platinum
5
Pemetrexed
5
1,2-diaminocyclohexaneplatinum II citrate
5
pembrolizumab
4
atezolizumab
2
Radiotherapy
2
Radiation
2
Nivolumab
2
Ipilimumab
2
Gemcitabine
2
Cyclophosphamide
2
Carboplatin
2
tremelimumab
1
methoxyamine
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cediranib
1
anetumab ravtansine
1
aldesleukin
1
Trioxsalen
1
Tissue Banks
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Phototherapy
1
Photochemotherapy
1
Pharmacogenomic Testing
1
Pharmaceutical Preparations
1
Interleukin-2
1
Influenza Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Tamoxifen
×
90 days
×
Clear all
No trials found.